125 related articles for article (PubMed ID: 3463867)
21. Combination of inhibitors of lymphocyte activation (hydroxyurea, trimidox, and didox) and reverse transcriptase (didanosine) suppresses development of murine retrovirus-induced lymphoproliferative disease.
Mayhew CN; Sumpter R; Inayat M; Cibull M; Phillips JD; Elford HL; Gallicchio VS
Antiviral Res; 2005 Jan; 65(1):13-22. PubMed ID: 15652967
[TBL] [Abstract][Full Text] [Related]
22. Synthesis and in vitro activity of long-chain 5'-O-[(alkoxycarbonyl)phosphinyl]-3'-azido-3'-deoxythymidines against wild-type and AZT- and foscarnet-resistant strains of HIV-1.
Rosowsky A; Fu H; Pai N; Mellors J; Richman DD; Hostetler KY
J Med Chem; 1997 Aug; 40(16):2482-90. PubMed ID: 9258355
[TBL] [Abstract][Full Text] [Related]
23. Double infection of BALB/c mice with Rauscher murine leukemia and Herpes simplex virus type 2.
Oleszak E; Inglot AD
Arch Immunol Ther Exp (Warsz); 1980; 28(2):337-44. PubMed ID: 6255890
[TBL] [Abstract][Full Text] [Related]
24. Long-term bone marrow stromal and hemopoietic toxicity to AZT: protective role of heme and IL-1.
Abraham NG; Chertkov JL; Staudinger R; Jiang S; Lutton JD; Argani I; Levere RD; Kappas A
Exp Hematol; 1993 Feb; 21(2):263-8. PubMed ID: 7678812
[TBL] [Abstract][Full Text] [Related]
25. Interferon-alpha and 3'-azido-3'-deoxythymidine are highly synergistic in mice and prevent viremia after acute retrovirus exposure.
Ruprecht RM; Chou TC; Chipty F; Sosa MG; Mullaney S; O'Brien L; Rosas D
J Acquir Immune Defic Syndr (1988); 1990; 3(6):591-600. PubMed ID: 2159992
[TBL] [Abstract][Full Text] [Related]
26. Transplacental carcinogenicity of 3'-azido-3'-deoxythymidine in B6C3F1 mice and F344 rats.
Walker DM; Malarkey DE; Seilkop SK; Ruecker FA; Funk KA; Wolfe MJ; Treanor CP; Foley JF; Hahn FF; Hardisty JF; Walker VE
Environ Mol Mutagen; 2007; 48(3-4):283-98. PubMed ID: 17358026
[TBL] [Abstract][Full Text] [Related]
27. Antiviral efficacy of Imexon in the Rauscher murine retrovirus AIDS model.
Chirigos MA; Ussery MA; Rankin JT; Herrmann D; Bicker U; Black PL
Immunopharmacol Immunotoxicol; 1990; 12(1):1-21. PubMed ID: 1693633
[No Abstract] [Full Text] [Related]
28. Maternal transmission of retroviral disease and strategies for preventing infection of the neonate.
Sharpe AH; Hunter JJ; Ruprecht RM; Jaenisch R
J Virol; 1989 Mar; 63(3):1049-53. PubMed ID: 2915376
[TBL] [Abstract][Full Text] [Related]
29. Human T-cell leukemia virus type I infects human lung epithelial cells and induces gene expression of cytokines, chemokines and cell adhesion molecules.
Teruya H; Tomita M; Senba M; Ishikawa C; Tamayose M; Miyazato A; Yara S; Tanaka Y; Iwakura Y; Fujita J; Mori N
Retrovirology; 2008 Sep; 5():86. PubMed ID: 18808681
[TBL] [Abstract][Full Text] [Related]
30. Mechanisms of genotoxicity of nucleoside reverse transcriptase inhibitors.
Olivero OA
Environ Mol Mutagen; 2007; 48(3-4):215-23. PubMed ID: 16395695
[TBL] [Abstract][Full Text] [Related]
31. Molecular characterization of human T-lymphotropic leukemia virus type III associated with the acquired immunodeficiency syndrome.
Wong-Staal F; Hahn BH; Shaw GM; Arya SK; Harper M; Gonda M; Gilden R; Ratner L; Starcich B; Okamoto T
Princess Takamatsu Symp; 1984; 15():291-300. PubMed ID: 6100646
[TBL] [Abstract][Full Text] [Related]
32. IL-2Ralpha-Directed monoclonal antibodies provide effective therapy in a murine model of adult T-cell leukemia by a mechanism other than blockade of IL-2/IL-2Ralpha interaction.
Phillips KE; Herring B; Wilson LA; Rickford MS; Zhang M; Goldman CK; Tso JY; Waldmann TA
Cancer Res; 2000 Dec; 60(24):6977-84. PubMed ID: 11156399
[TBL] [Abstract][Full Text] [Related]
33. Synthesis and antiviral activity of several 2,5'-anhydro analogues of 3'-azido-3'-deoxythymidine, 3'-azido-2',3'-dideoxyuridine, 3'-azido-2',3'-dideoxy-5-halouridines, and 3'-deoxythymidine against human immunodeficiency virus and Rauscher-murine leukemia virus.
Lin TS; Shen ZY; August EM; Brankovan V; Yang H; Ghazzouli I; Prusoff WH
J Med Chem; 1989 Aug; 32(8):1891-5. PubMed ID: 2754712
[TBL] [Abstract][Full Text] [Related]
34. Amplification of HTLV-III/LAV infection by antigen-induced activation of T cells and direct suppression by virus of lymphocyte blastogenic responses.
Margolick JB; Volkman DJ; Folks TM; Fauci AS
J Immunol; 1987 Mar; 138(6):1719-23. PubMed ID: 3493285
[TBL] [Abstract][Full Text] [Related]
35. [The effect of 3'-azido-2',3'-dideoxythymidine on experimental viral infections].
Shneĭder MA; Rudenko NK; Kavsan VM; Bibilashvili RSh; Kraevskiĭ AA
Mol Biol (Mosk); 1987; 21(3):837-46. PubMed ID: 2821379
[TBL] [Abstract][Full Text] [Related]
36. Different effect of benzylacyclouridine on the toxic and therapeutic effects of azidothymidine in mice.
Falcone A; Darnowski JW; Ruprecht RM; Chu SH; Brunetti I; Calabresi P
Blood; 1990 Dec; 76(11):2216-21. PubMed ID: 2257295
[TBL] [Abstract][Full Text] [Related]
37. A model for mixed virus disease: co-infection with Moloney murine leukemia virus potentiates runting induced by polyomavirus (A2 strain) in Balb/c and NIH Swiss mice.
Atencio IA; Belli B; Hobbs M; Cheng SF; Villarreal LP; Fan H
Virology; 1995 Oct; 212(2):356-66. PubMed ID: 7571405
[TBL] [Abstract][Full Text] [Related]
38. [The influence of macrophages on the leukemogenic activity of Rauscher murine leukemia virus].
Sydow G; Sydow H
Arch Geschwulstforsch; 1990; 60(4):279-82. PubMed ID: 2390004
[TBL] [Abstract][Full Text] [Related]
39. Murine models for antiretroviral therapy.
Ruprecht RM
Intervirology; 1989; 30 Suppl 1():2-11. PubMed ID: 2540110
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of mouse retroviral disease by bioactive glutaminase-asparaginase.
Roberts J; McGregor WG
J Gen Virol; 1991 Feb; 72 ( Pt 2)():299-305. PubMed ID: 1704410
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
